Siga Technologies To Begin First Human Trial Of Its Monkeypox Drug In September

Bloomberg Law (8/5, Muller, Subscription Publication) reported, “Siga Technologies Inc.’s Tpoxx [tecovirimat], a monkeypox treatment stockpiled by the US, will undergo its first rigorous human test in a trial slated to open as soon as September.” The arti...